NDC 50458-611 – Invega Hafyera
Paliperidone Palmitate 1092 mg/3.5mL · Injection, Suspension, Extended Release · Intramuscular
Product NDC50458-611
Product details
- Brand name
- Invega Hafyera
- Generic name
- Paliperidone palmitate
- Labeler
- Janssen Pharmaceuticals, Inc
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Intramuscular
- Marketing category
- NDA · NDA207946
- Marketed since
- August 30, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Paliperidone Palmitate 1092 mg/3.5mL
Uses, dosage, side effects and warnings for Invega Hafyera →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50458-611-01 | 1 SYRINGE in 1 CARTON (50458-611-01) / 3.5 mL in 1 SYRINGE | Aug 30, 2021 |
Other Invega Hafyera products
- 50458-612 Paliperidone Palmitate 1560 mg/5mL · Injection, Suspension, Extended Release · Janssen Pharmaceuticals, Inc